The Asia Pacific Drug Testing Market would witness market growth of 6.9% CAGR during the forecast period (2021-2027).
Maintaining a secure and efficient work environment is crucial for businesses and employees. The growth of the APAC region would be bolstered by the increasing drug & alcohol consumption, the imposition of strict mandating drug and alcohol testing, government investment in key markets, and regulatory approvals and product and services launches. The emerging drug abuse in India appears from the recent rapid economic development. Moreover, millions of Indians are significantly dependent on alcohol, opiates, cannabis, and drug misuse is highly prevalent in the country. In addition to it, drug abuse cases are increasing in this country which is putting an inordinate burden on the healthcare systems. Therefore, a need has been felt over the years for some effective drug testing regulations in order to reduce the cases and subsequently deliver the appropriate treatment.
Due to the outbreak of the COVID-19 pandemic, fingerprint-based drug testing is a comparatively new concept that has gained high popularity in recent years. The COVID-19 pandemic has made it hard to perform drug testing in labs, hospitals, and other facilities due to the possibility of transmission of the infection. Fingerprint-based drug testing can assist in curbing the spread of COVID-19 as it is non-invasive, less time-taking, hygienic, facilitates social distancing, user-friendly, portable, and needs no particular preparation for sample collection and handling. This test has extremely easy usage at any place and anytime, thereby providing flexible and efficient workplace drug testing. The test examines small traces of sweat in the fingerprint to identify the drug and drug metabolites. If this test is broadly accepted, it would substitute hair, urine, and blood-based drug tests. This is the main opportunity for the key market players to capitalize on in the global drug screening market.
The China market dominated the Asia Pacific Rapid Testing Devices Drug Testing Market by Country 2020, thereby, achieving a market value of $80.8 million by 2027. The Japan market is exhibiting a CAGR of 7.9% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 9.1% during (2021 - 2027).
Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Drug Testing Market is Projected to reach USD 11.7 Billion by 2027, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.
By Drug Type
By Sample Type
By Product Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
